What is Abacus Bioscience?
Abacus Bioscience is at the forefront of developing active immunotherapies designed to overcome immune tolerance. The company's scientific approach targets the complex treatment of cancer and chronic infections, aiming to push the boundaries of existing immunotherapy treatments. Their focus is on creating effective solutions for patients facing these severe health challenges, with a commitment to improving patient outcomes through innovative science.
How much funding has Abacus Bioscience raised?
Abacus Bioscience has raised a total of $4.4M across 1 funding round:
Angel/Seed
$4.4M
Angel/Seed (2023): $4.4M with participation from Sahsen Ventures, Alexandria Venture Investments, and Pack Ventures
Key Investors in Abacus Bioscience
Sahsen Ventures
Sahsen Ventures invests in mission-driven enterprises supporting life on Earth, with a focus on life sciences, social justice, and environmental sustainability. They provide philanthropic grants for research and for-profit financing for scaling practical implementations.
Alexandria Venture Investments
Alexandria Venture Investments is a key financial backer in Abacus Bioscience's latest funding round, contributing to the company's growth in the life sciences sector.
Pack Ventures
Pack Ventures, an early-stage capital provider within the University of Washington ecosystem, focuses on AI, life sciences, and deep-tech, offering strategic support and network access to portfolio companies like Abacus Bioscience.
What's next for Abacus Bioscience?
The recent major enterprise-level funding and strategic investment signal a pivotal moment for Abacus Bioscience, likely enabling accelerated clinical development, expansion of research initiatives, and potential market penetration. This capital infusion is expected to fuel the company's mission to extend the immunotherapy frontier and bring novel treatments to patients suffering from cancer and chronic infections. The strategic nature of the investment suggests a focus on scaling operations and solidifying market position.
See full Abacus Bioscience company page
